BeStock  
Stocks › Biotechnology › ARDX

Ardelyx ARDX

US equityMarket cap rank #3373Biotechnology
$3.26 −$0.05 (-1.51%)
Market closed · Oct 8, 7:10 am ET · Last extended-hours $3.28 +0.61%
Open$3.26
Prev close$3.31
Day range$3.22 – $3.35
Volume5.39M
Market cap$841.69M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$120.88M+23.8% YoY
Operating profit-$12.43M+13.7% YoY
Net profit-$16.72M+12.4% YoY
Diluted EPS-$0.07+12.5% YoY
Free cash flow-$6.41M+75.3% YoY
Operating cash flow-$6.40M

Revenue, last 8 quarters

$98.2MSep '24$116.1MDec '24$74.1MMar '25$97.7MJun '25$110.3MSep '25$125.2MDec '25$94.5MMar '26$120.9MJun '26

Net profit, last 8 quarters

$-809.0KSep '24$4.6MDec '24$-41.1MMar '25$-19.1MJun '25$-969.0KSep '25$-407.0KDec '25$-37.6MMar '26$-16.7MJun '26

Diluted EPS by quarter

0.00Sep '240.02Dec '24-0.17Mar '25-0.08Jun '250.00Sep '250.00Dec '25-0.15Mar '26-0.07Jun '26

Free cash flow by quarter

$364.0KSep '24$9.2MDec '24$-38.8MMar '25$-26.0MJun '25$209.0KSep '25$20.6MDec '25$-32.3MMar '26$-6.4MJun '26

Annual revenue

$7.6MFY20$10.1MFY21$52.2MFY22$124.5MFY23$333.6MFY24$407.3MFY25

Profitability & balance sheet

Gross margin94.4%
Operating margin-7.9%
Net margin-12.4%
Return on equity-38.6%
Return on assets-10.7%
Return on invested capital-10.2%
Current ratio3.34
Liabilities / assets74.1%
Cash & investments$281.83M
Total debt$254.65M
Net cash (debt)$27.19M

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Product sales, net$118.13M 97.7%
  • Other revenues$2.75M 2.3%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $120.88M $94.47M $407.32M $125.22M $110.33M
Total Operating Revenue $120.88M $94.47M $407.32M $125.22M $110.33M
Cost of Revenue $5.76M $4.81M $39.54M $10.85M $3.98M
Gross Profit $115.12M $89.66M $367.78M $114.37M $106.35M
Operating Expense $127.54M $122.46M $408.76M $109.27M $101.68M
Selling and Admin Expenses $101.44M $102.27M $337.23M $86.41M $83.61M
Research & Development $26.10M $20.19M $71.53M $22.86M $18.07M
Operating Profit -$12.43M -$32.79M -$40.98M $5.10M $4.67M
Net Non-Operating Interest Income (Expense) -$6.22M -$6.92M -$28.40M -$7.58M -$7.98M
Non-Operating Interest Expense $6.22M $6.92M $28.40M $7.58M $7.98M
Other Income (Expense) $2.04M $2.11M $8.75M $2.08M $2.45M
Other Non-Operating Income (Expenses) $2.04M $2.11M $8.75M $2.08M $2.45M
Pretax Profit -$16.61M -$37.60M -$60.63M -$400,000.00 -$867,000.00
Tax $110,000.00 $8,000.00 $969,000.00 $7,000.00 $102,000.00
Net Profit -$16.72M -$37.61M -$61.60M -$407,000.00 -$969,000.00
Profit from Continuing Operations -$16.72M -$37.61M -$61.60M -$407,000.00 -$969,000.00
Net Income to Parent Company -$16.72M -$37.61M -$61.60M -$407,000.00 -$969,000.00
Net Income to Common Stockholders -$16.72M -$37.61M -$61.60M -$407,000.00 -$969,000.00
Basic EPS -$0.07 -$0.15 -$0.26 $0.00 $0.00
Diluted EPS -$0.07 -$0.15 -$0.26 $0.00 $0.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $575.89M $504.51M $501.60M $501.60M $486.17M
Total Current Assets $441.93M $381.87M $382.32M $382.32M $367.99M
Cash and Cash Equivalents & Short-Term Investments $281.83M $238.07M $264.69M $264.69M $242.71M
-Cash and Cash Equivalents $97.19M $31.21M $68.00M $68.00M $42.72M
-Short Term Investments $184.64M $206.87M $196.69M $196.69M $199.99M
Receivables $100.35M $82.84M $71.85M $71.85M $76.61M
-Accounts Receivable $100.35M $82.84M $71.85M $71.85M $76.61M
Prepaid Assets $14.70M $14.64M $14.48M $14.48M $8.05M
Inventory $25.86M $22.75M $17.74M $17.74M $25.17M
Other Current Assets $19.19M $23.58M $13.57M $13.57M $15.45M
Total Non-Current Assets $133.97M $122.64M $119.29M $119.29M $118.19M
Net PPE $5.85M $6.44M $6.98M $6.98M $7.22M
-Gross PPE $5.85M $6.44M $9.63M $9.63M $7.22M
Non-Current Prepaid Assets $8.49M $4.24M – – –
Other Non-Current Assets $119.63M $111.96M $112.31M $112.31M $110.96M
Total Liabilities $426.88M $355.89M $334.66M $334.66M $331.89M
Total Current Liabilities $132.22M $109.57M $88.61M $88.61M $83.39M
Payables $38.41M $28.20M $19.24M $19.24M $18.39M
-Accounts Payable $38.41M $28.20M $19.24M $19.24M $18.39M
Current Accrued Expenses $70.96M $67.23M $40.23M $40.23M $41.93M
Short-Term Debt and Capital Lease Obligation $1.55M $1.51M $1.48M $1.48M $1.44M
-Current Capital Lease Obligation $1.55M $1.51M $1.48M $1.48M $1.44M
Current Deferred Liabilities $6.74M $3.25M $1.21M $1.21M $6.58M
Total Non-Current Liabilities $294.66M $246.32M $246.05M $246.05M $248.50M
Long Term Debt and Capital Lease Obligation $254.65M $206.75M $206.48M $206.48M $206.18M
-Long Term Debt $251.82M $203.52M $202.83M $202.83M $202.14M
-Long Term Capital Lease Obligation $2.82M $3.24M $3.64M $3.64M $4.04M
Non-Current Deferred Liabilities $40.02M $39.56M $39.58M $39.58M $42.33M
Total Equity $149.01M $148.62M $166.95M $166.95M $154.28M
Stockholders' Equity $149.01M $148.62M $166.95M $166.95M $154.28M
Capital Stock $25,000.00 $25,000.00 $24,000.00 $24,000.00 $24,000.00
-Common Stock $25,000.00 $25,000.00 $24,000.00 $24,000.00 $24,000.00
Additional Paid-In Capital $1.15B $1.13B $1.11B $1.11B $1.10B
Retained Earnings -$1.00B -$984.54M -$946.94M -$946.94M -$946.53M
Gains/Losses Not Affecting Retained Earnings -$193,000.00 -$124,000.00 $198,000.00 $198,000.00 $124,000.00
-Accumulated Depreciation – – -$2.65M -$2.65M –
Other Current Liabilities – – $7.35M $7.35M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$6.40M -$32.24M -$42.48M $20.95M $365,000.00
Net cash flow from continuing operations -$6.40M -$32.24M -$42.48M $20.95M $365,000.00
Net Income from Continuing Operations -$16.72M -$37.61M -$61.60M -$407,000.00 -$969,000.00
Depreciation & Depletion & Amortization $604,000.00 $915,000.00 $3.06M $921,000.00 $905,000.00
Other Non-Cash Items $743,000.00 $678,000.00 -$1.55M $326,000.00 -$3.07M
Change in Working Capital -$6.34M -$10.38M -$31.35M $7.67M -$9.24M
-Change in Receivables -$17.51M -$10.99M -$14.14M $4.76M -$14.06M
-Change in Inventory -$10.96M -$4.92M -$31.92M $6.25M -$6.10M
-Change in Prepaid Assets $200,000.00 -$14.40M -$2.39M -$4.95M $4.84M
-Change in Payables and Accrued Expense $18.82M $18.26M $21.95M $7.33M $4.58M
-Change in Other Current Liabilities -$380,000.00 -$373,000.00 -$1.83M -$353,000.00 -$206,000.00
-Change In Other Working Capital $3.49M $2.04M -$3.01M -$5.38M $1.71M
Net cash flow from investing $22.66M -$10.00M -$8.96M $3.78M -$50.51M
Net Cash Flow from Continuing Investing Activities $22.66M -$10.00M -$8.96M $3.78M -$50.51M
Net PPE Purchase and Sale -$13,000.00 -$69,000.00 -$1.49M -$361,000.00 -$156,000.00
Net Investment Purchase and Sale $22.67M -$9.93M -$7.47M $4.14M -$50.35M
Financing Cash Flow $49.72M $5.44M $54.51M $557,000.00 $2.81M
Net Cash Flow from Continuing Financing Activities $49.72M $5.44M $54.51M $557,000.00 $2.81M
Proceeds from Stock Option Exercised $1.68M $5.44M $5.84M $557,000.00 $2.81M
Ending Cash Balance $97.19M $31.21M $68.00M $68.00M $42.72M
Net Change in Cash $65.98M -$36.79M $3.07M $25.28M -$47.33M
Beginning Cash Balance $31.21M $68.00M $64.93M $42.72M $90.05M
Free Cash Flow -$6.41M -$32.31M -$43.98M $20.59M $209,000.00
Net Issuance Payments Of Debt – – $48.67M $0.00 $0.00
Net Common Stock Issuance – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on ARDX.

Leave a comment

Scroll to Top